Kestra Medical Technologies, Ltd. (KMTS) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

good afternoon and welcome to the castra medical technologies third quarter fiscal 2025 earnings conference call this conference call is being recorded for replay purposes we will be facilitating a question and answer session following prepared remarks from management at this time all participants are in a listen only mode i would now like to turn the call over to neil baladkar vice president of investor relations. Please go ahead. Thanks, Lateef. Thank you all for joining Kestra's third quarter fiscal 2025 earnings call. With me today are Brian Webster, President and Chief Executive Officer, and Vasim Meboob, Chief Financial Officer. This call includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements. These statements are based on Kestra's current expectations, forecasts, and assumptions, which are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Actual outcomes and results could differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements due to various factors. Please review Kestra's most recent filings with the SEC, particularly the risk factors described in our registration statement on Form S-1 for additional information. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today. Kestra undertakes no obligations to update these statements except as required by applicable law. With that, I'll turn the call over to Brian. Thanks, Neil. Good afternoon, everyone, and welcome to Kestra's first ear...